PB 94 of 2022
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022
I, Nikolai Tsyganov, as delegate for the Minister for Health and Aged Care, make the following determination.
Dated 27 September 2022
Nikolai Tsyganov
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Definitions
5 Floor price of certain brands of pharmaceutical items
1 Name
(1) This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022.
(2) This instrument may also be cited as PB 94 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 October 2022. | 1 October 2022 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.
4 Definitions
In this instrument:
Act means the National Health Act 1953.
brand has the same meaning as in Part VII of the Act.
pharmaceutical item has the same meaning as in Part VII of the Act.
5 Floor price of certain brands of pharmaceutical items
For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand of a pharmaceutical item mentioned in column 1 of an item in the following table.
Note: Columns 2, 3 and 4 of the table are included for information only.
Floor price of certain brands of pharmaceutical items | ||||
Item | Column 1 | Column 2 | Column 3 Form | Column 4 Manner of administration |
1 | Dantrium
| Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
2 | Cardizem
| Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
3 | Diltiazem AN
| Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
4 | Vasocardol | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
5 | DBL Heparin Sodium | Heparin | Injection 5,000 units (as sodium) in 0.2 ml | Injection |
6 | Moduretic
| Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
7 | Penthrox
| Methoxyflurane | Liquid for inhalation 999 mg per g, 3 ml (with inhaler) | Inhalation by mouth |
8 | Asmol CFC-Free with dose counter
| Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |
9 | Ventolin CFC-Free with dose counter
| Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |
10 | Zempreon CFC-Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |